Skip to main content

Advertisement

Table 5 Correlation between survival and combined marker expression

From: Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancer

  No. Cumulative survival (%) Median ± SE 95% CI p. value
Nm23 (-)& p53 (+) 9 11 6 ± 1.49 3.08 – 8.92  
Other combinations 50 57 43 ± - - 0.0004
Nm23 (-)& EGFR (+) 18 28 10 ± 3.18 3.76 – 16.24  
Other combinations 41 60 43 ± - - 0.029
EGFR (+)& p53 (+) 11 18 6 ± 3.85 0 – 13.55  
Other combinations 48 58 43 ± - - 0.0002
Nm23 (-), p53 (+), EGFR (+) 6 15 5.8 ± 3.85 0.1–13.55 0.0001
Other combinations 53 59 43 ± - -  
Nm23 (-), p53 (+), EGFR (+)& b (-) 7 9 4 ± 5.62 1.45 – 20.21 <0.0001
Other combinations 52 58 50 ± - -